The mortality rate for patients with acute myeloid leukemia (AML) is still high. Cytogenetic features are the most important prognostic parameter, and the most appropriate treatment of intermediate risk AML (IR-AML), which accounts for about 60% of AML, is controversial. Our study suggested that the D value obtained from intravoxel incoherent motion (IVIM) could play a potential role in predicting treatment response of IR-AML patients. Moreover, f value and D* value in an IVIM model can independently predict OS of patients with IR-AML. These findings suggest that IVIM parameters can be useful imaging markers to predict prognosis for IR-AML.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords